News Releases Archive — Page 29 of 39
Recent and archived press releases with clinical and research news
-
March 29, 2024
What happens when musicians lose their hearing? Many find their way to VUMC’s Katie Berg — a scientist, a clinician — and a musician.
Cochlear implants can restore the ability to hear speech, but not music. In the heart of Music City, Katie Berg helps fit cochlear implants tuned specially for the needs of musicians. -
March 29, 2024
A gunshot to the head. A long recovery. Then a wedding.
Special Agent Adam Daniels celebrates ongoing recovery after gunshot causes traumatic brain injury; family’s gift will support care of others with similar injuries -
March 29, 2024
VUMC nurses lead Pearl-Cohn career fair to showcase health care careers to high school students
The fair featured a multidisciplinary group, including nursing, social work, EMS, pharmacy, medicine and surgical and radiology technologists. -
March 28, 2024
Teams to create one-stop resource for human pancreatic data to foster diabetes research
Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research. -
March 27, 2024
Higher genetic risk of obesity means working out harder for same results
Study authors used activity, clinical and genetic data from the National Institutes of Health’s All of Us Research Program to explore the association of genetic risk of higher body mass index and the level of physical activity needed to reduce incident obesity. -
March 26, 2024
Keep an eye on safety during April 8 solar eclipse
Eye safety should be a priority when viewing the eclipse on April 8. -
March 26, 2024
GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes
The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.